DCPA Registration Review; Draft Occupational and Residential Risk Assessment; Notice of Availability, 35869-35871 [2023-11664]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 105 / Thursday, June 1, 2023 / Notices
Center (Premcor) and ExxonMobil
Pipeline Company’s Des Plaines
Terminal (ExxonMobil), both located in
Cook County, Illinois.
ADDRESSES: The final Order, the
Petitions, and other supporting
information are available for public
inspection during normal business
hours at the following address:
Environmental Protection Agency,
Region 5, Air and Radiation Division, 77
West Jackson Boulevard, Chicago,
Illinois 60604. This facility is open from
8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding Federal holidays and
facility closures due to COVID–19. We
recommend that you contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section before
visiting the Region 5 office.
Additionally, the final Order and
Petitions are available electronically at:
https://www.epa.gov/title-v-operatingpermits/title-v-petition-database.
FOR FURTHER INFORMATION CONTACT:
Danny Marcus, Air Permits Section, Air
Programs Branch (AR–18J),
Environmental Protection Agency,
Region 5, 77 West Jackson Boulevard,
Chicago, Illinois 60604, (312) 353–8781,
marcus.danny@epa.gov.
SUPPLEMENTARY INFORMATION:
Throughout this document whenever
‘‘we,’’ ‘‘us,’’ or ‘‘our’’ is used, we mean
EPA.
The CAA affords EPA a 45-day period
to review and object to, as appropriate,
operating permits proposed by state
permitting authorities under title V of
the CAA. Section 505(b)(2) of the CAA
authorizes any person to petition the
EPA Administrator to object to a title V
operating permit within 60 days after
the expiration of EPA’s 45-day review
period if EPA has not objected on its
own initiative. Petitions must be based
only on objections to the permit that
were raised with reasonable specificity
during the public comment period
provided by the state, unless the
petitioner demonstrates that it was
impracticable to raise these issues
during the comment period or unless
the grounds for the issues arose after
this period.
On July 23, 2022, EPA received the
Premcor Petition from the Petitioner
requesting that EPA object to IEPA’s
July 11, 2022, modification of Premcor’s
operating permit no. 96030063. The
Premcor Petition alleges that IEPA’s
issuance of the permit modification was
unlawful because IEPA improperly
processed a significant change to testing
requirements in Premcor’s permit as a
minor modification. The Petitioner
structured the Premcor Petition into the
following five ‘‘claims’’: (1) IEPA
VerDate Sep<11>2014
17:37 May 31, 2023
Jkt 259001
relaxed testing requirements without
public outreach, in violation of IEPA’s
environmental justice (EJ) practices and
policies; (2) IEPA made changes to the
permit based on a ‘‘secretive template’’;
(3) the ‘‘sheer amount of changes’’ that
IEPA appears to have made to the
permit is enough to show a public
comment period was warranted; (4)
IEPA made changes to title I
construction permits that should have
been considered a significant change to
the permit; and (5) the permit
modification allows the facility to delay
testing, which is a violation of human
rights and will result in ‘‘no testing ever
being conducted’’ and no
‘‘demonstration of compliance.’’
On November 14, 2022, EPA received
the ExxonMobil Petition from the
Petitioner requesting that EPA object to
IEPA’s July 11, 2022, modification of
ExxonMobil’s operating permit no.
95060060. Similar to the Premcor
Petition, the ExxonMobil Petition
alleges that IEPA improperly processed
a significant change to testing
requirements in ExxonMobil’s title V
permit as a minor modification. The
Petitioner structured the ExxonMobil
Petition into the following two
‘‘claims’’: (1) IEPA violated its EJ
practices and policies by relaxing a
‘‘critical air pollution control device test
requirement’’ without conducting
public outreach and failed to give the
public an opportunity to comment on
the ‘‘gross relaxation’’ of testing at the
terminal; and (2) IEPA deleted testing
requirements in violation of human
rights.
On May 1, 2023, the EPA
Administrator issued an Order denying
both Petitions. The Order explains the
basis for EPA’s decision.
Sections 307(b) and 505(b)(2) of the
CAA provide that a petitioner may
request judicial review of those portions
of an order that deny issues in a
petition. Any petition for review of the
Administrator’s May 1, 2023, Order
shall be filed in the United States Court
of Appeals for the appropriate circuit no
later than July 31, 2023.
Authority: 42 U.S.C. 7401 et seq.
Dated: May 25, 2023.
Debra Shore,
Regional Administrator, Region 5.
[FR Doc. 2023–11635 Filed 5–31–23; 8:45 am]
BILLING CODE 6560–50–P
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
35869
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OPP–2011–0374; FRL–10959–01–
OCSPP]
DCPA Registration Review; Draft
Occupational and Residential Risk
Assessment; Notice of Availability
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
This notice announces the
availability of EPA’s draft human health
occupational and residential risk
assessment for the registration review of
Dimethyl Tetrachloroterephthalate
(DCPA) for the registered uses of DCPA
and opens a public comment period on
the assessment. The risk assessment is
accompanied by several related
documents, including an assessment of
the benefits associated with the use of
DCPA and a companion document to
aid in interpretation of the risk
assessment and provide an explanation
of the approach being considered by
EPA to address the potential risks.
DATES: Comments must be received on
or before July 3, 2023.
ADDRESSES: Submit your comments,
identified by docket identification (ID)
number EPA–HQ–OPP–2011–0374,
through the Federal eRulemaking Portal
at https://www.regulations.gov. Follow
the online instructions for submitting
comments. Do not submit electronically
any information you consider to be
Confidential Business Information (CBI)
or other information whose disclosure is
restricted by statute. Additional
instructions on commenting and visiting
the docket, along with more information
about dockets generally, is available at
https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
James Douglass, Chemical Review
Manager, Pesticide Re-Evaluation
Division (7508M), Office of Pesticide
Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460–0001; telephone
number: (202) 566–2343; email address:
douglass.james@epa.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. General Information
A. Does this action apply to me?
This action is directed to the public
in general and may be of interest to a
wide range of stakeholders including
environmental, human health, farm
worker, and agricultural advocates; the
chemical industry; pesticide users; and
members of the public interested in the
sale, distribution, or use of pesticides.
Since others also may be interested, the
E:\FR\FM\01JNN1.SGM
01JNN1
35870
Federal Register / Vol. 88, No. 105 / Thursday, June 1, 2023 / Notices
Agency has not attempted to describe all
the specific entities that may be affected
by this action. If you have any questions
regarding the applicability of this action
to a particular entity, consult the
Chemical Review Manager listed under
FOR FURTHER INFORMATION CONTACT.
ddrumheller on DSK120RN23PROD with NOTICES1
B. What should I consider as I prepare
my comments for EPA?
1. Submitting CBI. Do not submit this
information to EPA through
regulations.gov or email. Clearly mark
the part or all of the information that
you claim to be CBI. For CBI
information in a disk or CD–ROM that
you mail to EPA, mark the outside of the
disk or CD–ROM as CBI and then
identify electronically within the disk or
CD–ROM the specific information that
is claimed as CBI. In addition to one
complete version of the comment that
includes information claimed as CBI, a
copy of the comment that does not
contain the information claimed as CBI
must be submitted for inclusion in the
public docket. Information so marked
will not be disclosed except in
accordance with procedures set forth in
40 CFR part 2.
2. Tips for preparing your comments.
When preparing and submitting your
comments, see the commenting tips at
https://www.epa.gov/dockets/
commenting-epa-dockets.
3. Environmental justice. EPA seeks to
achieve environmental justice, the fair
treatment and meaningful involvement
of any group, including minority and/or
low-income populations, in the
development, implementation, and
enforcement of environmental laws,
regulations, and policies. To help
address potential environmental justice
issues, the Agency seeks information on
any groups or segments of the
population who, as a result of their
location, cultural practices, or other
factors, may have atypical or
disproportionately high and adverse
human health impacts or environmental
effects from exposure to the pesticide
discussed in this document, compared
to the general population.
II. Background
Registration review is EPA’s periodic
review of pesticide registrations to
ensure that each pesticide continues to
satisfy the statutory standard for
registration, that is, the pesticide can
perform its intended function without
unreasonable adverse effects on human
health or the environment. Through this
program, required by FIFRA section
3(g), 7 U.S.C. 136a(g), EPA must ensure
that each pesticide’s registration is
based on current scientific and other
knowledge, including its effects on
VerDate Sep<11>2014
17:37 May 31, 2023
Jkt 259001
human health and the environment. As
part of the registration review process,
the Agency has completed a draft
occupational and residential risk
assessment for the registered uses of
DCPA. DCPA is an herbicide used to
control grassy and broadleaf weeds on a
variety of use sites including cole crops,
onions, and turf. The Agency is taking
the unusual step of publishing the
DCPA occupational and residential risk
assessment in advance of other pieces of
the human health risk assessment and
the ecological risk assessment because
of newly submitted data on the toxicity
of DCPA. These data, from a
Comparative Thyroid Assay conducted
in rats, suggest that there are potential
risks for people exposed to DCPA
during their work and leisure activities.
The Agency anticipates that there is the
potential for some pregnant workers to
be exposed to levels of DCPA that are
sufficient to cause thyroid hormone
perturbations in the fetuses they are
carrying. In order to determine the best
path forward, the Agency is seeking
comments on the draft occupational and
residential risk assessment. The
assessment is accompanied by several
related documents, including an
assessment of the benefits associated
with the use of DCPA and a companion
document to aid in interpretation of the
risk assessment and to explain the
approach being considered by EPA to
address the potential risks. After
reviewing comments received during
the public comment period, EPA plans
to respond to those comments and, if
warranted, will issue a revised risk
assessment. EPA encourages public
input on all aspects of the assessment
and mitigation of the potential
occupational and residential risks for
DCPA. The Agency will also keep the
public advised on aspects related to risk
mitigation as warranted.
III. Authority
EPA is conducting its registration
review of DCPA pursuant to section 3(g)
of the Federal Insecticide, Fungicide,
and Rodenticide Act (FIFRA) and the
Procedural Regulations for Registration
Review at 40 CFR part 155, subpart C.
Section 3(g) of FIFRA provides, among
other things, that the registrations of
pesticides are to be reviewed every 15
years. Under FIFRA, a pesticide product
may be registered or remain registered
only if it meets the statutory standard
for registration given in FIFRA section
3(c)(5) (7 U.S.C. 136a(c)(5)). When used
in accordance with widespread and
commonly recognized practice, the
pesticide product must perform its
intended function without unreasonable
adverse effects on the environment; that
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
is, without any unreasonable risk to
man or the environment, or a human
dietary risk from residues that result
from the use of a pesticide in or on food.
IV. What action is the Agency taking?
Pursuant to 40 CFR 155.53(c), this
notice announces the availability of
EPA’s draft human health occupational
and residential risk assessment for the
pesticide DCPA and opens a 30-day
public comment period on the risk
assessment. In order to expedite Agency
action to address the risks posed by
DCPA, the comment period will not be
extended. The Agency will consider all
comments received during the public
comment period and make changes, as
appropriate, to the draft risk assessment.
After the close of the public comment
period, EPA may, as needed, issue a
revised occupational and residential
risk assessment, explain any changes to
the draft risk assessment, and respond
to comments. Public comments received
during the 30-day comment period will
help inform the Agency’s next steps.
Unless any new information comes to
light during this time that significantly
changes the risk conclusions, the
Agency is considering if cancellation of
all DCPA product registrations is
necessary.
Information Submission Requirements
Anyone may submit data or
information in response to this
document. To be considered during a
pesticide’s registration review, the
submitted data or information must
meet the following requirements:
• To ensure that EPA will consider
data or information submitted,
interested persons must submit the data
or information during the comment
period. The Agency may, at its
discretion, consider data or information
submitted at a later date.
• The data or information submitted
must be presented in a legible and
useable form. For example, an English
translation must accompany any
material that is not in English, and a
written transcript must accompany any
information submitted as an audio
graphic or videographic record. Written
material may be submitted in paper or
electronic form.
• Submitters must clearly identify the
source of any submitted data or
information.
• Submitters may request the Agency
to reconsider data or information that
the Agency rejected in a previous
review. However, submitters must
explain why they believe the Agency
should reconsider the data or
information in the pesticide’s
registration review.
E:\FR\FM\01JNN1.SGM
01JNN1
Federal Register / Vol. 88, No. 105 / Thursday, June 1, 2023 / Notices
As provided in 40 CFR 155.58, the
registration review docket for DCPA will
remain publicly accessible through the
duration of the registration review
process; that is, until all actions
required in the final decision on the
registration review case have been
completed.
Authority: 7 U.S.C. 136 et seq.
Dated: May 25, 2023.
Mary Elissa Reaves,
Director, Pesticide Re-Evaluation Division,
Office of Pesticide Programs.
[FR Doc. 2023–11664 Filed 5–31–23; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[FRL–10983–01–OA]
Public Meeting of the Science Advisory
Board
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
The Environmental Protection
Agency (EPA) Science Advisory Board
(SAB) Staff Office is announcing a
public meeting of the chartered Science
Advisory Board. The purpose of the
meeting is to discuss recommendations
received from the SAB Work Group for
Review of Science Supporting EPA
Decisions concerning SAB review of
EPA planned regulatory actions.
DATES: Public Meeting: The chartered
Science Advisory Board will meet on
Friday, June 23, 2023, from 12 noon to
5 p.m. Eastern Time.
Comments: See the section titled
‘‘Procedures for Providing Public Input’’
under SUPPLEMENTARY INFORMATION for
instructions and deadlines.
ADDRESSES: The meeting will be
conducted virtually. Please refer to the
SAB website at https://sab.epa.gov for
information on how to attend the
meeting.
SUMMARY:
Any
member of the public who wants further
information concerning this notice may
contact Dr. Thomas Armitage,
Designated Federal Officer (DFO), via
telephone (202) 564–2155, or email at
armitage.thomas@epa.gov. General
information about the SAB, as well as
any updates concerning the meeting
announced in this notice, can be found
on the SAB website at https://
sab.epa.gov.
ddrumheller on DSK120RN23PROD with NOTICES1
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
Background: The SAB was
established pursuant to the
Environmental Research, Development,
VerDate Sep<11>2014
17:37 May 31, 2023
Jkt 259001
and Demonstration Authorization Act
(ERDDAA), codified at 42 U.S.C. 4365,
to provide independent scientific and
technical advice to the EPA
Administrator on the scientific and
technical basis for agency positions and
regulations. The SAB is a Federal
Advisory Committee chartered under
the Federal Advisory Committee Act
(FACA), 5 U.S.C. app. 2. The SAB will
comply with the provisions of FACA
and all appropriate SAB Staff Office
procedural policies. Pursuant to FACA
and EPA policy, notice is hereby given
that the chartered Science Advisory
Board will hold a public meeting to
discuss and deliberate on
recommendations received from the
SAB Work Group for Review of Science
Supporting EPA Decisions concerning
SAB review of EPA planned regulatory
actions.
Under the SAB’s authorizing statute,
the SAB ‘‘may make available to the
Administrator, within the time specified
by the Administrator, its advice and
comments on the adequacy of the
scientific and technical basis’’ of
proposed rules. The SAB Work Group
for Review of Science Supporting EPA
Decisions (SAB SSD Work Group) is
charged with identifying EPA planned
actions that may warrant SAB review.
The SAB will discuss recommendations
received from the SAB SSD Work
Group.
Availability of Meeting Materials: All
meeting materials, including the agenda,
will be available on the SAB web page
at https://sab.epa.gov.
Procedures for Providing Public Input:
Public comment for consideration by
EPA’s federal advisory committees and
panels has a different purpose from
public comment provided to EPA
program offices. Therefore, the process
for submitting comments to a federal
advisory committee is different from the
process used to submit comments to an
EPA program office. Federal advisory
committees and panels, including
scientific advisory committees, provide
independent advice to the EPA.
Members of the public can submit
relevant comments pertaining to the
committee’s charge or meeting
materials. Input from the public to the
SAB will have the most impact if it
provides specific scientific or technical
information or analysis for the SAB to
consider or if it relates to the clarity or
accuracy of the technical information.
Members of the public wishing to
provide comment should follow the
instruction below to submit comments.
Oral Statements: In general,
individuals or groups requesting an oral
presentation at a meeting conducted
virtually will be limited to three
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
35871
minutes. Each person making an oral
statement should consider providing
written comments as well as their oral
statement so that the points presented
orally can be expanded upon in writing.
Persons interested in providing oral
statements should contact the DFO, in
writing (preferably via email) at the
contact information noted above in the
FOR FURTHER INFORMATION CONTACT, by
June 19, 2023, to be placed on the list
of registered speakers.
Written Statements: Written
statements will be accepted throughout
the advisory process; however, for
timely consideration by SAB members,
statements should be submitted to the
DFO by June 19, 2023, for consideration
at the June 23, 2023, meeting. Written
statements should be supplied to the
DFO at the contact information above
via email. Submitters are requested to
provide an unsigned version of each
document because the SAB Staff Office
does not publish documents with
signatures on its websites. Members of
the public should be aware that their
personal contact information if included
in any written comments, may be posted
to the SAB website. Copyrighted
material will not be posted without the
explicit permission of the copyright
holder.
Accessibility: For information on
access or services for individuals with
disabilities, please contact the DFO, at
the contact information noted above,
preferably at least ten days prior to the
meeting, to give the EPA as much time
as possible to process your request.
V. Khanna Johnston,
Deputy Director, Science Advisory Board Staff
Office.
[FR Doc. 2023–11631 Filed 5–31–23; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[FRL–10942–01–R6]
Underground Injection Control
Program; Hazardous Waste Injection
Restrictions; Petition for Exemption
Reissuance—Class I Hazardous Waste
Injection; Dow Beaumont Aniline Plant,
Texas
Environmental Protection
Agency (EPA).
ACTION: Notice of a final decision on a
no migration petition reissuance.
AGENCY:
Notice is hereby given that a
reissuance of an exemption to the land
disposal restrictions, under the 1984
Hazardous and Solid Waste
Amendments to the Resource
SUMMARY:
E:\FR\FM\01JNN1.SGM
01JNN1
]]>Agencies
[Federal Register Volume 88, Number 105 (Thursday, June 1, 2023)]
[Notices]
[Pages 35869-35871]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11664]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPP-2011-0374; FRL-10959-01-OCSPP]
DCPA Registration Review; Draft Occupational and Residential Risk
Assessment; Notice of Availability
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the availability of EPA's draft human
health occupational and residential risk assessment for the
registration review of Dimethyl Tetrachloroterephthalate (DCPA) for the
registered uses of DCPA and opens a public comment period on the
assessment. The risk assessment is accompanied by several related
documents, including an assessment of the benefits associated with the
use of DCPA and a companion document to aid in interpretation of the
risk assessment and provide an explanation of the approach being
considered by EPA to address the potential risks.
DATES: Comments must be received on or before July 3, 2023.
ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2011-0374, through the Federal eRulemaking
Portal at https://www.regulations.gov. Follow the online instructions
for submitting comments. Do not submit electronically any information
you consider to be Confidential Business Information (CBI) or other
information whose disclosure is restricted by statute. Additional
instructions on commenting and visiting the docket, along with more
information about dockets generally, is available at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: James Douglass, Chemical Review
Manager, Pesticide Re-Evaluation Division (7508M), Office of Pesticide
Programs, Environmental Protection Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460-0001; telephone number: (202) 566-2343; email
address: [email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public in general and may be of
interest to a wide range of stakeholders including environmental, human
health, farm worker, and agricultural advocates; the chemical industry;
pesticide users; and members of the public interested in the sale,
distribution, or use of pesticides. Since others also may be
interested, the
[[Page 35870]]
Agency has not attempted to describe all the specific entities that may
be affected by this action. If you have any questions regarding the
applicability of this action to a particular entity, consult the
Chemical Review Manager listed under FOR FURTHER INFORMATION CONTACT.
B. What should I consider as I prepare my comments for EPA?
1. Submitting CBI. Do not submit this information to EPA through
regulations.gov or email. Clearly mark the part or all of the
information that you claim to be CBI. For CBI information in a disk or
CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as
CBI and then identify electronically within the disk or CD-ROM the
specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.
2. Tips for preparing your comments. When preparing and submitting
your comments, see the commenting tips at https://www.epa.gov/dockets/commenting-epa-dockets.
3. Environmental justice. EPA seeks to achieve environmental
justice, the fair treatment and meaningful involvement of any group,
including minority and/or low-income populations, in the development,
implementation, and enforcement of environmental laws, regulations, and
policies. To help address potential environmental justice issues, the
Agency seeks information on any groups or segments of the population
who, as a result of their location, cultural practices, or other
factors, may have atypical or disproportionately high and adverse human
health impacts or environmental effects from exposure to the pesticide
discussed in this document, compared to the general population.
II. Background
Registration review is EPA's periodic review of pesticide
registrations to ensure that each pesticide continues to satisfy the
statutory standard for registration, that is, the pesticide can perform
its intended function without unreasonable adverse effects on human
health or the environment. Through this program, required by FIFRA
section 3(g), 7 U.S.C. 136a(g), EPA must ensure that each pesticide's
registration is based on current scientific and other knowledge,
including its effects on human health and the environment. As part of
the registration review process, the Agency has completed a draft
occupational and residential risk assessment for the registered uses of
DCPA. DCPA is an herbicide used to control grassy and broadleaf weeds
on a variety of use sites including cole crops, onions, and turf. The
Agency is taking the unusual step of publishing the DCPA occupational
and residential risk assessment in advance of other pieces of the human
health risk assessment and the ecological risk assessment because of
newly submitted data on the toxicity of DCPA. These data, from a
Comparative Thyroid Assay conducted in rats, suggest that there are
potential risks for people exposed to DCPA during their work and
leisure activities. The Agency anticipates that there is the potential
for some pregnant workers to be exposed to levels of DCPA that are
sufficient to cause thyroid hormone perturbations in the fetuses they
are carrying. In order to determine the best path forward, the Agency
is seeking comments on the draft occupational and residential risk
assessment. The assessment is accompanied by several related documents,
including an assessment of the benefits associated with the use of DCPA
and a companion document to aid in interpretation of the risk
assessment and to explain the approach being considered by EPA to
address the potential risks. After reviewing comments received during
the public comment period, EPA plans to respond to those comments and,
if warranted, will issue a revised risk assessment. EPA encourages
public input on all aspects of the assessment and mitigation of the
potential occupational and residential risks for DCPA. The Agency will
also keep the public advised on aspects related to risk mitigation as
warranted.
III. Authority
EPA is conducting its registration review of DCPA pursuant to
section 3(g) of the Federal Insecticide, Fungicide, and Rodenticide Act
(FIFRA) and the Procedural Regulations for Registration Review at 40
CFR part 155, subpart C. Section 3(g) of FIFRA provides, among other
things, that the registrations of pesticides are to be reviewed every
15 years. Under FIFRA, a pesticide product may be registered or remain
registered only if it meets the statutory standard for registration
given in FIFRA section 3(c)(5) (7 U.S.C. 136a(c)(5)). When used in
accordance with widespread and commonly recognized practice, the
pesticide product must perform its intended function without
unreasonable adverse effects on the environment; that is, without any
unreasonable risk to man or the environment, or a human dietary risk
from residues that result from the use of a pesticide in or on food.
IV. What action is the Agency taking?
Pursuant to 40 CFR 155.53(c), this notice announces the
availability of EPA's draft human health occupational and residential
risk assessment for the pesticide DCPA and opens a 30-day public
comment period on the risk assessment. In order to expedite Agency
action to address the risks posed by DCPA, the comment period will not
be extended. The Agency will consider all comments received during the
public comment period and make changes, as appropriate, to the draft
risk assessment. After the close of the public comment period, EPA may,
as needed, issue a revised occupational and residential risk
assessment, explain any changes to the draft risk assessment, and
respond to comments. Public comments received during the 30-day comment
period will help inform the Agency's next steps. Unless any new
information comes to light during this time that significantly changes
the risk conclusions, the Agency is considering if cancellation of all
DCPA product registrations is necessary.
Information Submission Requirements
Anyone may submit data or information in response to this document.
To be considered during a pesticide's registration review, the
submitted data or information must meet the following requirements:
To ensure that EPA will consider data or information
submitted, interested persons must submit the data or information
during the comment period. The Agency may, at its discretion, consider
data or information submitted at a later date.
The data or information submitted must be presented in a
legible and useable form. For example, an English translation must
accompany any material that is not in English, and a written transcript
must accompany any information submitted as an audio graphic or
videographic record. Written material may be submitted in paper or
electronic form.
Submitters must clearly identify the source of any
submitted data or information.
Submitters may request the Agency to reconsider data or
information that the Agency rejected in a previous review. However,
submitters must explain why they believe the Agency should reconsider
the data or information in the pesticide's registration review.
[[Page 35871]]
As provided in 40 CFR 155.58, the registration review docket for
DCPA will remain publicly accessible through the duration of the
registration review process; that is, until all actions required in the
final decision on the registration review case have been completed.
Authority: 7 U.S.C. 136 et seq.
Dated: May 25, 2023.
Mary Elissa Reaves,
Director, Pesticide Re-Evaluation Division, Office of Pesticide
Programs.
[FR Doc. 2023-11664 Filed 5-31-23; 8:45 am]
BILLING CODE 6560-50-P
